Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Gains 10%; BSE HEALTHCARE Index Up 1.2%
Tue, 10 Sep 15:51

PIRAMAL PHARMA Gains 10%; BSE HEALTHCARE Index Up 1.2%Image source: phive2015/www.istockphoto.com

PIRAMAL PHARMA share price has zoomed 10% and is presently trading at Rs 237.9.

Meanwhile, the BSE HEALTHCARE index is at 43,879.3 (up 1.2%).

Among the top gainers in the BSE HEALTHCARE index today are Divis Laboratories (up 4.8%) and SYNGENE INTERNATIONAL (up 4.0%).

NARAYANA HRUDAYALAYA (down 1.9%) and GSK Pharma (down 1.4%) are among the top losers today.

Over the last one year, PIRAMAL PHARMA has moved up from Rs 103.8 to Rs 237.9, registering a gain of Rs 134.1 (up 129.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,357.7 to 43,879.3, registering a gain of 54.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 131.2%), Jubilant Pharmova (up 124.2%) and GRANULES INDIA (up 122.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,939.0 (up 0.5%).

The top gainers among the BSE Sensex today are NTPC (up 2.3%) and Bharti Airtel (up 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,051.3 (up 0.5%). Divis Laboratories and LTIMINDTREE are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,880.5 to 81,939.0, registering a gain of 16,058.5 points (up 24.4%).

PIRAMAL PHARMA Financial Update...

PIRAMAL PHARMA net profit grew 1.7% YoY to Rs -1,110 million for the quarter ended June 2024, compared to a loss of Rs 1,130 million a year ago. Net sales rose 11.6% to Rs 19,511 million during the period as against Rs 17,489 million in April-June 2023.

For the year ended March 2024, PIRAMAL PHARMA reported 109.6% increase in net profit to Rs 178 million compared to net loss of Rs 1,865 million during FY23. Revenue of the company grew 15.4% to Rs 81,712 million during FY24.

The current Price to earnings ratio of PIRAMAL PHARMA, based on rolling 12 month earnings, stands at -793.6.


Equitymaster requests your view! Post a comment on "PIRAMAL PHARMA Gains 10%; BSE HEALTHCARE Index Up 1.2%". Click here!